CJC-1295 no DAC 5mg / Ipamorelin 5mg – Synergistic Growth Hormone Research Blend
 
CJC-1295 / Ipamorelin is a high-purity peptide combination designed to investigate the dual-action stimulation of growth hormone pathways in advanced laboratory research settings. This 1:1 ratio blend is formulated to study the concurrent activation of the pituitary gland through two distinct biochemical mechanisms.
 
This formulation pairs CJC-1295 no DAC (a GHRH analog) with Ipamorelin (a selective GHSR agonist). In experimental models, this synergistic blend is studied for its ability to mimic the natural, pulsatile release of growth hormone by simultaneously stimulating the pituitary gland and inhibiting somatostatin. Researchers utilize this combination to analyze metabolic regulation, cellular repair mechanisms, and the modulation of lean muscle mass and adipose tissue metabolism. By utilizing the "no DAC" version of CJC-1295, researchers can observe acute endocrine signaling patterns without the prolonged systemic exposure associated with long-acting analogs.
 
This advanced research blend is frequently utilized in laboratory settings to study endocrine signaling, metabolic efficiency, and the biochemical pathways of systemic recovery and cellular homeostasis.
 
CJC-1295 no DAC (5mg)
CAS#: 446036-97-1
Molecular Weight: $3367.94$ g/mol
Chemical Formula: $C_{152}H_{252}N_{44}O_{42}$
 
Ipamorelin (5mg)
CAS#: 170851-70-4
Molecular Weight: $711.868$ g/mol
Chemical Formula: $C_{38}H_{49}N_{9}O_{5}$
High purity: 99% HPLC
Blend Ratio: 1:1 (5mg each per vial)
Research-grade quality
 
For laboratory research use only. Not for human or veterinary consumption.
 
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.